This content is machine translated Pediatric corner Cutaneous manifestations of Lyme disease: case series. Lyme disease is the most common tick-borne infectious disease in Europe. If Lyme disease is detected early, it can be treated well with antibiotics. A typical early-stage skin condition is…
View Post 6 min This content is machine translated Atopic dermatitis Skin microbiome normalizes under tralokinumab therapy Atopic dermatitis is associated with dysbiosis of the cutaneous microbiome. Characteristic is reduced bacterial diversity, with Staphylococcus aureus often being the dominant bacterial genus. In a recent study, it was…
View Post 10 min This content is machine translated Histamine intolerance Why the HIT is not a hit: myths and facts Histamine intolerance (HIT) is a food intolerance that involves a series of adverse reactions as a result of accumulated or ingested histamine. It is caused by an imbalance between the… CME-Test
View Post 5 min This content is machine translated Specialist guideline asthma New recommendations for the everyday life of specialists The national S3 care guideline on bronchial asthma in Germany was updated in 2020. This guideline also has acceptance in Switzerland and has a very high level of evidence, but…
View Post 6 min This content is machine translated Atopic eczema EuroGuiDerm guideline – overview of current recommendations for system therapy Recently, there have been significant advances in the treatment of atopic dermatitis, including several new systemic therapeutic options overcoming regulatory hurdles. This has also been incorporated into the EuroGuiDerm guideline…
View Post 5 min This content is machine translated Corona Pandemic Current findings on Long-Covid – initial treatment options and therapeutic approaches. In the Zurich Coronavirus Cohort Study, one in four participants reported persistent symptoms six months after SARS-CoV-2 infection. What are the underlying pathophysiological mechanisms of long-covid? Which treatment strategies are…
View Post 3 min This content is machine translated Plaque psoriasis New “Real World” Study on Tildrakizumab In a retrospective study of 30 patients with moderate to severe plaque psoriasis, the use of the IL-23 inhibitor tildrakizumab was shown to be effective and safe in clinical practice.…
View Post 5 min This content is machine translated Atopic dermatitis in the era of precision medicine Research into molecular biomarkers opens up new horizons The identification and study of molecular biomarkers may help to dissect the complex phenotype of atopic dermatitis into subphenotypes. A long-term goal of this translational research is the stratification and…
View Post 6 min This content is machine translated Study Report Palmoplantar psoriasis – a diagnostic challenge Because many clinical and histopathologic features of palmoplantar psoriasis (PP) overlap with those of other dermatoses, differential diagnosis is far from trivial. With this in mind, a research team analyzed…
View Post 3 min This content is machine translated Plaque psoriasis Current 5-year data on secukinumab A long-term extension analysis of the ERASURE and FIXTURE studies recently published in the British Journal of Dermatology demonstrates the long-lasting efficacy and safety of secukinumab in patients with moderate-to-severe…
View Post 8 min This content is machine translated Translational medicine Psoriasis – from immunopathogenesis to successful therapy The innovative systemic treatments for psoriasis are a prime example of translational medicine. In a review published last year in the Journal of Investigative Dermatology, Prof. Peter van de Kerkhof,…
